Browsing by Publisher "Bayrakol Medical Publisher"
Now showing items 1-3 of 3
-
Chronic delta hepatitis: a single-center experience
(Bayrakol Medical Publisher, 2020)Aim: Chronic Delta Hepatitis (CDH) is characterized by rapid progressive liver disease. The only treatment option accepted today is pegylated interferon. In this study, we aimed to share the results of the patients who ... -
Feasibility of laparoscopic approach in malignant and benign adrenal lesions
(Bayrakol Medical Publisher, 2020)Aim: The approach to adrenal lesions is still controversial, especially concerning the potentially malignant masses. This study aims to present the results of laparoscopic adrenalectomy of a tertiary referral center, and ... -
The role of anti-thyroglobulin antibody in treatment and follow up of differentiated thyroid cancer
(Bayrakol Medical Publisher, 2020)Aim: This study aimed to investigate the role of serum anti-thyroglobulin antibody (anti-TgAb) as a marker to predict the success of radioactive iodine (RAI) ablation therapy in differentiated thyroid cancer (DTC) patients ...
